Galectin Therapeutics Ownership | Who Owns Galectin Therapeutics?

Galectin Therapeutics Ownership Summary

Galectin Therapeutics is owned by 15.77% institutional investors, 30.08% insiders, and 54.15% retail investors. Vanguard group is the largest institutional shareholder, holding 3.43% of GALT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.12% of its assets in Galectin Therapeutics shares.

GALT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Galectin Therapeutics	15.77%	30.08%	54.15%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	2.14M	3.43%	$2.76M
Blackrock	1.56M	2.52%	$3.53M
Advisor group	1.18M	1.90%	$3.25M
Blackrock funding, inc. /de	891.88K	1.41%	$1.88M
Geode capital management	870.59K	1.40%	$1.12M
Wealthspire advisors	479.52K	0.76%	$1.01M
Geneos wealth management	360.18K	0.57%	$1.53M
Commonwealth equity services	294.90K	0.46%	$1.25M
State street	229.62K	0.37%	$518.93K
Morgan stanley	227.22K	0.37%	$513.51K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Retirement guys formula	165.99K	0.25%	$702.98K
Solutions 4 wealth	36.00K	0.13%	$75.97K
Vivaldi capital management lp	172.44K	0.05%	$363.86K
Geneos wealth management	360.18K	0.04%	$1.53M
Soltis investment advisors	140.75K	0.02%	$181.57K
Traynor capital management	98.10K	0.02%	$217.78K
Advisor group	1.18M	0.01%	$3.25M
Beacon capital management	23.91K	0.01%	$50.44K
Cahaba wealth management	21.00K	0.01%	$88.94K
Wealthspire advisors	479.52K	0.01%	$1.01M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.56M	0.00%	851.14K
Vivaldi capital management lp	172.44K	0.05%	116.81K
Wealthspire advisors	479.52K	0.01%	81.14K
Hrt financial lp	77.20K	0.00%	77.20K
State street	229.62K	-	68.17K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	891.88K	-	-523.03K
Y-intercept (hong kong)	-	-	-235.19K
Atria wealth solutions	-	-	-186.00K
Cutter & co brokerage	-	-	-115.49K
Susquehanna group, llp	10.25K	-	-71.21K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	30.40K	0.00%	30.40K	$64.14K
Hightower advisors	22.49K	-	22.49K	$29.01K
Summit trail advisors	20.00K	0.00%	20.00K	$42.20K
Point72 asia (singapore) pte.	14.59K	0.01%	14.59K	$30.78K
Tang capital management	12.91K	0.00%	12.91K	$27.25K

Sold Out

Holder	Change
Legal & general group	-38.00
Sterling capital management	-74.00
Group one trading	-542.00
Nelson, van denburg & campbell wealth management group	-600.00
Amalgamated bank	-705.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	88	-7.37%	9,965,158	0.59%	15	6.42%	36	24.14%	22	-26.67%
Mar 31, 2025	94	-14.55%	9,893,813	-1.83%	15	5.98%	30	-53.13%	29	222.22%
Dec 31, 2024	110	23.60%	10,078,323	3.40%	16	6.61%	64	64.10%	9	-50.00%
Sep 30, 2024	87	14.47%	9,657,327	1.46%	15	6.57%	39	-11.36%	17	112.50%
Jun 30, 2024	76	22.58%	9,518,560	24.93%	15	9.58%	44	100.00%	8	-20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.36M	2.12%	-29.90K
Vanguard US Total Market Shares ETF	1.25M	1.97%	-
Vanguard Institutional Extnd Mkt Idx Tr	543.11K	0.85%	-173.52K
Fidelity Extended Market Index	268.61K	0.42%	-879.00
Fidelity Small Cap Index	142.93K	0.23%	-17.81K
iShares Russell 2000 Growth ETF	103.67K	0.16%	-
iShares Micro-Cap ETF	101.44K	0.16%	-
BlackRock Extended Equity Market K	92.01K	0.15%	-39.00
Extended Equity Market Fund K	89.26K	0.14%	-1.78K
Fidelity Total Market Index	87.23K	0.14%	-186.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 22, 2025	10X Fund, L.P.	-	Sell	$148.20K
Oct 22, 2025	10X Fund, L.P.	-	Sell	$98.60K
Sep 12, 2025	CALLICUTT JACK W	Chief Financial Officer	Sell	$56.05K
Sep 12, 2025	LEWIS JOEL	President and CEO	Sell	$89.05K
Jul 21, 2025	ELDRED KARY	-	Buy	$2.92K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	2
2025 Q3	2	2
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	8	3

GALT Ownership FAQ

Who Owns Galectin Therapeutics?

Galectin Therapeutics shareholders are primarily institutional investors at 15.77%, followed by 30.08% insiders and 54.15% retail investors. The average institutional ownership in Galectin Therapeutics's industry, Biotech Stocks , is 307.10%, which Galectin Therapeutics falls below.

Who owns the most shares of Galectin Therapeutics?

Galectin Therapeutics’s largest shareholders are Vanguard group (2.14M shares, 3.43%), Blackrock (1.56M shares, 2.52%), and Advisor group (1.18M shares, 1.90%). Together, they hold 7.85% of Galectin Therapeutics’s total shares outstanding.

Does Blackrock own Galectin Therapeutics?

Yes, BlackRock owns 2.52% of Galectin Therapeutics, totaling 1.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.53M$. In the last quarter, BlackRock increased its holdings by 851.14K shares, a 119.44% change.

Who is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested?

Retirement guys formula is Galectin Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.25% of its assets in 165.99K Galectin Therapeutics shares, valued at 702.98K$.

Who is the top mutual fund holder of Galectin Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Galectin Therapeutics shares, with 2.12% of its total shares outstanding invested in 1.36M Galectin Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools